Probiodrug to attend and present at European Conferences in November 2015
B2B-E-Commerce und SAP: Über die richtige Brücke muss es gehen
Noxxon: Börsengang an der Euronext geplant
IPO VON NOXXON PHARMA
Probiodrug presented data on its pGlu-3 Abeta monoclonal Antibody at Neuroscience 2015, ChicagoPresentation at the Society for Neuroscience (SfN) Annual Meeting
Probiodrug reports Third Quarter 2015 Business Update
Probiodrug to present at US and Japanese Conferences
Antibody Drug Conjugate Using CTATTM Linker Technology Shows SuperiorEfficacy in Xenograft Trial.
Probiodrug collaborates with the Paul-Flechsig-Institute for Brain Research, Leipzig University, Germany
Vetro Solar auf dem Vormarsch - Solarglas-Unternehmen hat so viele Aufträge wie nie zuvor
